Dietary Intervention for Feeding Difficulties in Large Infants
Trial Summary
What is the purpose of this trial?
Large for Gestational Age (LGA) infants have excess fat-mass (FM) proportion secondary to prolonged in utero exposure to an energy-rich environment. Our preliminary data suggest that excess FM proportion can be associated with oral feeding delay and a potentially modifiable therapeutic target to improve oral feeding outcomes. The objective of this study is to determine the impact of a short-term Fat-free mass (FFM)-indexed feeding on the oral intake volumes in LGA infants with oral feeding difficulties.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Dietary Intervention for Feeding Difficulties in Large Infants?
Research shows that a team approach, including nutritional management, is effective in addressing feeding difficulties in infants by considering various factors like nutrition, medical status, and social situation. Additionally, maternal dietary counseling has been shown to reduce the intake of energy-dense foods in infants, which can be beneficial in managing feeding difficulties.12345
Is dietary intervention for feeding difficulties in large infants safe?
How is the dietary intervention treatment for feeding difficulties in large infants different from other treatments?
Eligibility Criteria
This trial is for large-for-gestational-age (LGA) infants born at or after 35 weeks, who have trouble with oral feeding and a body composition showing excess fat. Infants must not be on respiratory support, have certain swallowing issues, GI surgeries, serious neurological conditions, or major congenital/genetic disorders.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Infants are randomized to either FFM-indexed feeding or standard feeding for 2 weeks
Follow-up
Participants are monitored for clinical and growth outcomes until NICU discharge and through 6 months of age
Treatment Details
Interventions
- Dietary intervention (Dietary Intervention)